Opyl makes a strategic board recruitment as it looks to commercialise its product offerings

The recruitment of Dr Megan Robertson to the Opyl’s board will give the company the depth and experience it needs to expand the business globally.


“We are extremely pleased to welcome Megan to the board. Megan brings an enormous amount of clinical and commercial experience and in- depth knowledge in the health sector which will contribute significantly to the company’s strategy,” commented Opyl chairman, Dr Julian Chick.

This is only an excerpt from an article written by Stockhead. The full version can be found here.